Zobrazeno 1 - 10
of 379
pro vyhledávání: '"Frenkl A"'
Autor:
Balar, Arjun V *, Kamat, Ashish M, Kulkarni, Girish S, Uchio, Edward M, Boormans, Joost L, Roumiguié, Mathieu, Krieger, Laurence E M, Singer, Eric A, Bajorin, Dean F, Grivas, Petros, Seo, Ho Kyung, Nishiyama, Hiroyuki, Konety, Badrinath R, Li, Haojie, Nam, Kijoeng, Kapadia, Ekta, Frenkl, Tara, de Wit, Ronald
Publikováno v:
In The Lancet Oncology July 2021 22(7):919-930
Autor:
Fradet, Y. *, Bellmunt, J., Vaughn, D.J., Lee, J.L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Nam, K., Frenkl, T.L., Perini, R.F., de Wit, R., Bajorin, D.F.
Publikováno v:
In Annals of Oncology June 2019 30(6):970-976
Autor:
Mitcheson, Henry D., Samanta, Suvajit, Muldowney, Karen, Pinto, Cathy A., Rocha, Beatriz de A., Green, Stuart, Bennett, Nathan, Mudd, Paul N., Jr, Frenkl, Tara L.
Publikováno v:
In European Urology February 2019 75(2):274-282
Autor:
Fox, Michelle C., Klipping, Christine, Nguyen, Allison Martin, Frenkl, Tara L., Cruz, Sandra M., Wang, Yinna, Korver, Tjeerd
Publikováno v:
In Contraception February 2019 99(2):125-130
Autor:
Nicholas C Turner, David W Cescon, Sibylle Loibl, Wolfgang Janni, Hope Rugo, Judith Balmaña, Cheynna Crowley, Jon Chung, Giulia Fucli, Erin Hofstatter, Tara Frenkl, Melinda L Telli
Publikováno v:
Cancer Research. 82:OT2-24
Background: Following definitive treatment, there is no standard-of-care for patients (pts) with HR+HER2− breast cancer (BC) or TNBC beyond clinical monitoring for metastasis. Recurrence rates remain high for pts with a greater burden of residual d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb619bab1881d1cc49207230ad37caa2
https://doi.org/10.1158/1538-7445.sabcs21-ot2-24-02
https://doi.org/10.1158/1538-7445.sabcs21-ot2-24-02
Autor:
Laurence Eliot Miles Krieger, Arjun Vasant Balar, Petros Grivas, Eric A. Singer, Haojie Li, Tara L. Frenkl, Ashish M. Kamat, Girish S. Kulkarni, Badrinath R. Konety, Edward Uchio, Hiroyuki Nishiyama, Joost L. Boormans, Kijoeng Nam, Ekta Kapadia, Dean F. Bajorin, Ronald de Wit, Mathieu Roumiguié, Ho Kyung Seo
Publikováno v:
The Lancet Oncology, 22(7), 919-930. Lancet Publishing Group
Summary Background Standard treatment for high-risk non-muscle-invasive bladder cancer is transurethral resection of bladder tumour followed by intravesical BCG immunotherapy. However, despite high initial responses rates, up to 50% of patients have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::310576cb36126232e3959fc6c4f2e4b8
https://doi.org/10.1016/s1470-2045(21)00147-9
https://doi.org/10.1016/s1470-2045(21)00147-9
Autor:
Balar, A. V., Kamat, A. M., Kulkarni, G. S., Uchio, E. M., Boormans, J. L., Roumiguié, M., Krieger, L. E.M., Singer, E. A., Bajorin, D. F., Grivas, P., Seo, H. K., Nishiyama, H., Konety, B. R., Li, H., Nam, K., Kapadia, E., Frenkl, T., De Wit, R.
Publikováno v:
Journal of Urology, 208(1). Elsevier Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::daa84f23196a379dd20f5fd78642aa72
https://pure.eur.nl/en/publications/b221f526-6e44-4896-907c-6a5982a65d65
https://pure.eur.nl/en/publications/b221f526-6e44-4896-907c-6a5982a65d65
Autor:
Peter H. O'Donnell, Petros Grivas, Blanca Homet Moreno, Joaquim Bellmunt, Elizabeth R. Plimack, Mary J. Savage, Daniel Castellano, Xiao Fang, Dean F. Bajorin, Ronald de Wit, Thomas Powles, Tara L. Frenkl, Arjun Vasant Balar, Jacqueline Vuky, Noah M. Hahn, James Luke Godwin
Publikováno v:
Journal of Clinical Oncology, 38(23), 2658-+. American Society of Clinical Oncology
PURPOSE The phase II single-arm KEYNOTE-052 study evaluated the efficacy and safety of first-line pembrolizumab for patients with locally advanced or metastatic cisplatin-ineligible urothelial carcinoma (UC). PATIENTS AND METHODS Three hundred sevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7dc84f018142d34aefa6e59f423c85a
https://doi.org/10.1200/jco.19.01213
https://doi.org/10.1200/jco.19.01213
Autor:
Shahrokh F. Shariat, Tara L. Frenkl, Ashish M. Kamat, Hiroyuki Nishiyama, Gary D. Steinberg, Shaheen Alanee, Kijoeng Nam, Ekta Kapadia, Neal D. Shore, Noah M. Hahn
Publikováno v:
Future Oncology. 16(10):507-516
Background: Nonmuscle-invasive bladder cancer (NMIBC) is the most common form of bladder cancer, with high rates of disease recurrence and progression. Current treatment for high-risk NMIBC involves Bacillus Calmette-Guérin (BCG) therapy, but treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d345cab957f404d7db0807efb85eca2
https://tsukuba.repo.nii.ac.jp/records/2001688
https://tsukuba.repo.nii.ac.jp/records/2001688
Autor:
James Luke Godwin, Dean F. Bajorin, Joaquim Bellmunt, Petros Grivas, Tara L. Frenkl, Thomas Powles, Misoo C. Ellison, Arjun Vasant Balar, Jacqueline Vuky, Daniel Castellano, Ronald de Wit, Noah M. Hahn, Elizabeth R. Plimack, Peter H. O'Donnell
Publikováno v:
European urology oncology
European urology oncology, 3(3), 351-359. Elsevier
European urology oncology, 3(3), 351-359. Elsevier
Background: Patients with treatment-naive advanced urothelial cancer (UC) Ineligible for cisplatin-based chemotherapy are typically older and have comorbidities, representing a difficult-to-treat population. Objective: To evaluate the safety and anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1c661cea767882d1d3eb214810c31e
https://doi.org/10.1016/j.euo.2020.02.009
https://doi.org/10.1016/j.euo.2020.02.009